December 2006 Issue of MMM
As a geography major—yes, geography—I have to confess to having fond memories of presentations on demographics and socio-economic trends.
Whew, what a night! Almost 700 medical marketers and publishers ascended on New Yorks Tavern on the Green, Nov. 2, for the MMM Awards 2006, ...
With the Democrats set to take control of Congress, the new guard of committee leadership presents a mixed-to-bleak picture for pharma industry interests.
Details of more than 250 therapeutics and vaccines in development, including analyst comments on key products.
When it comes to digital communication, pharma has been slow out of the blocks. But while drug companies may rue their fast-diminishing ability to control ...
With major blockbusters going generic and fewer products being launched, manufacturers face continued downward pressure on prices. The pharmaceutical market is changing…and so should marketers.
Asked for his take on things now that Amgen is launching its first-ever cancer therapeutic, Jim Daly responds cheerfully.
In attending the MMM Awards dinner recently, I was asked to present an award for the best unbranded TV ad.
The FDA's Scott Gottlieb offered a conditional endorsement of the recommendations of the Institutes of Medicine report and vowed that the agency will communicate better ...
Med Ed Report
The ACCME is taking its show on the road to enhance member understanding of its new accreditation model.
The National Commission for the Certification of CME Professionals’ voluntary certification program will not be out until fall 2007.
Next month's meeting of the Alliance for CME (ACME) will be the last for Bruce Bellande, PhD, as executive director.
Funding from Novo Nordisk and Medscape/WebMD helped outcomes journal CE Measure make its October debut.
The UC Davis medical center’s executive committee is set to decide on several recommendations, one a ban on all gifts that includes payments from industry ...
Alan Lotvin, MD, formerly president and COO of medical education provider M|C Communications, resigned from the company effective Sept. 1.
Robert Orsetti, MA, FACME, has joined Educational Measures as EVP, working from its New Jersey office.
Pharma services firm inVentiv Health has acquired The Maxwell Group for $7 million in cash and stock.
Monthly Prescribing Reference is targeting pharmacists with a new edition aimed at providing them a counter-top quick-reference.
Mercks Fosamax three-page professional ads and Daiichi Sankyo's one-page Evoxac ad took top honors at the Doctors Choice Awards.
The American College of Rheumatology (ACR) is partnering with John Wiley & Sons to launch The Rheumatologist, a new controlled-circulation magazine.
Advanstar named Jeff Bauer managing editor for RN Magazine.
Quadrant HealthCom appointed Leslie Baran product manager for Meeting Architect, a new product line from Physicians' Travel & Meeting Guide aimed at convention exhibitors.
Haymarkets Clinical Advisor won a Folio: Magazine Eddie Gold Award as best business-to-business publication in Healthcare/Medical/Nursing, trumping Advance for Healthy Aging, Dental Practice Report and ...
Pharmas are spending more on print ads and less on TV as they seek to get right with PhRMAs DTC guidelines and present more exhaustive ...
Eight out of every 10 people that use the Internet go online for health information and most of these people start with a search engine.
Pharma marketers now have an added opportunity to connect with healthcare professionals with the debut of an innovative search engine designed by CMPMedica.
HealthMedia, a realtionship marketing firm focus ing on behavioral change, has acquired consumer health Web site MySelfHelp.com.
In an ever-changing marketplace, pharma marketers must always be working on ways to foster patient relationships, according to the marketing VP behind Sanofi-Aventis blockbuster Ambien ...
Specialty pharma company Santarus has hired 140 sales reps from contract sales firm inVentiv Commercial Services to bolster efforts behind its heartburn treatment Zegerid.
Contract sales provider PDI said Sanofi-Aventis would end its $20 million sales agreement with the firm, effective Dec. 1. It was set to expire Dec. ...
Contract sales firm PDI has hired David Stievater as SVP, emerging pharma.
MediZine hired Eileen Bruno, Brooks Crandall and Jamie Blocher to assist in the launch of its new magazine distributed to medical specialists' offices, MDminute.
Contract sales firm Publicis Selling Solutions Group hired Rick Keefer as COO.
Sales and marketing solutions provider Dendrite International has entered into a deal with Microsoft aimed at developing new sales solutions on the Microsoft software platform.
Roche dipped a webbed foot into entertainment industry partnerships with a tie-in to the animated penguin romp “Happy Feet” that stands to benefit its Tamiflu ...
Novartis shifted the DTC account for Diovan from Deutsch to Hill, Holliday, Connors, Cosmopoulos.
Warning and untitled letters on broadcast and print DTC ads have plummeted since PhRMA’s adoption of its Guiding Principles on DTC in August 2005.
Lilly credited increased Cymbalta sales for a 7% gain in overall sales for the 3rd Quarter, and said marketing and administrative costs were up 12%, ...
Rodale named Mary Murcko VP, publisher of Women's Health. Previously at Rodale's Best Life, of which she was founding publisher, Murcko succeeds Kate Kelly Smith.
DLifeTV, the diabetes "lifestyle" program, debuted on TiVoCast, through which TiVo owners can download shows directly.
Incoming Committee on Government Reform Chair Rep. Henry Waxman (D-CA) reiterated his request that the FDA conduct a thorough scientific review of phenylephrine's effectiveness at ...
HHS Deputy Secretary Alex Azar lobbied the UK government to legalize DTC ads, according to The Guardian.
A year ago, if you told a pharmaceutical industry lobbyist that Nancy Pelosi would be Madame Speaker, Ted Kennedy would chair the Senate Health, Education, ...
Charlotte Beers, the former undersecretary of state for public diplomacy and public affairs, called for pharma companies to confront their critics and stand up for ...
Pfizer named Weber Shandwick PR agency of record for Lipitor following a break with WPP.
Keep your eyes on the Democrats' government reform chairman, Henry A. Waxman, when the new Congress convenes.
FDA deputy commissioner for medical and scientific affairs Scott Gottlieb says he is confident additional resources will be allocated for the agency’s drug safety efforts ...
FDA Office of New Drugs director John Jenkins said concerns over drug safety and "gaming" of the review clock were not to blame for a ...
The FDA says it is continuing its battle against unapproved drugs with a consent decree signed with one manufacturer of unapproved drugs and Warning Letters ...
Former FDA commissioner Lester Crawford's criminal behavior while in office was "blatant," according to District of Columbia US Attorney Jeffrey A. Taylor in a statement ...
The FDA says development of a potentially life-threatening serotonin syndrome may occur in treatment with four selective serotonin reuptake inhibitors.
The FDA's director of orphan products development for the past 19 years, Marlene Haffner, will retire in January to join the biotech firm Amgen as ...
Eli Lilly says it will appeal the FDA's decision to issue an "approvable letter" that requests an additional efficacy study for Arxxant, its new drug ...
Wyeth and the FDA are warning healthcare professionals about an overdose potential for patients taking the antidepressant Effexor.
A US Customs and Border Protection program to seize personal drug prescriptions shipped from Canada has been scrapped.
Sens. Frist and Clinton are both on record as supporting the push for computerizing medical record keeping.
- Guidemark Health merges with three companies to form new agency
- Five things for pharma marketers to know: Monday, October 17, 2016
- Five things for pharma marketers to know: Thursday, October 20, 2016
- Five things for pharma marketers to know: Tuesday, October 18, 2016
- Five things for pharma marketers to know: Wednesday, October 19, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- If Roche's Ocrevus is approved, the already competitive MS market will gain another player
- Top 25 neurology products, based on 2016 sales forecasts
- New science drives biopharma interest in neurological conditions
- J&J exec calls California pricing measure 'misguided'
- Five things for pharma marketers to know: Monday, October 24, 2016